Practice/Trial Run 

On Tuesday October 12 from 11:00 -12:00 (PST), 
ALL poster presenters
 are REQUIRED to login to SpatialChat here: (
https://spatial.chat/s/PGRN-ASHG-2021) to: 

  1. Test SpatialChat

  2. Double check that your poster PNG image that we received and uploaded is correct. 

  3. Ensure that your audio/video works as expected.

POSTERS

POSTER # FIRST NAME LAST NAME ABSTRACT TITLE AUTHORS
A3 Alaa Alsaafin Does genetic variation in a bitter taste recepor gene alter early smoking behaviors in youth Alaa Alsaafin*, Meghan J. Chenoweth, Marie-Pierre Sylvestre, Jennifer O’Loughlin, Rachel F. Tyndale
A33 Mina Azimi Species-specific functional differences in the ABC transporter P-glycoprotein Mina Azimi*, Sook Wah Yee, Kathleen M. Giacomini
A12 Khalil Ben Hassine Inclusion of GSTA1 polymorphisms in busulfan first dose personalization for pediatric hematopoietic stem cell transplantation recipients. Khalil Ben Hassine *, Tiago Nava, Yves Théoret, Christa E. Nath, Youssef Daali, Nastya Kassir, Victor Lewis, Robert G M Bredius, Peter J. Shaw, Henrique Bittencourt, Maja Krajinovic, Chakradhara Rao Satyanarayana Uppugunduri, and Marc Ansari
A5 Emma Charlotte Bernsen Implementation of pre-emptive pharmacogenetic screening in pediatric oncology. E.C. Bernsen*, T.W. Kouwenberg, M.M. Hagleitner, L.M. Hanff, A.D.R. Huitema1, M.H.M. Diekstra
A42 Katherine Black Pediatric CYP2D6 Metabolizer Status and Post-Tonsillectomy Nausea and Vomiting After Ondansetron Administration Katherine Black*; B. Randall Brenn, Andrea Gaedigk, Jonathan P. Wanderer, Sara Van Dries,
A15 Ross Booyse Identification of cytochrome P450 oxidoreductase alleles in African populations using publicly available whole genome sequence data. Ross Booyse*
A37 Jamaica Roanne Briones Prioritisation of Clinically Actionable Gene-Drug Pairs for Cost-effectiveness Analyses in Singapore Alexander Michael Labeit, Jamaica Roanne Briones*, Folefac Aminkeng, Jia Hui Chai, Boon Cher Goh, Liuh Ling Goh, Khai Pang Leong, Elaine Lo, Kee Yuan Ngiam, E Shyong Tai, Karen ML Tan, Doreen Su-Yin Tan, Michael David Winther, Benedict Yan, Yaroslava Zemlyanska, Hwee Lin Wee
B13 Carsten Bruckner Space-optimized HLA typing using Axiom™ PGx research solutions C. Bruckner*
A25 Dina Buitrago Silva Functional Genomics of Rare Coding Region Variants in the GABA Transporter, GAT-1 (SLC6A1) Dina Buitrago Silva*1, Stephan Sanders1, Kathleen Giacomini1
B10 Alessandra Campos Staffico ABCB1 DIPLOTYPE IS ASSOCIATED WITH BLEEDING FROM RIVAROXABAN Alessandra M. Campos-Staffico*, Angel Edwards, Sarah Hanigan, Kristen Pogue, Michael P. Dorsch, Jasmine A Luzum
A40 Alanna Cera Clinical pharmacogenomic test reporting preferences among adult and pediatric providers A. Cera*, H. Naik, R. M. Wasserman, B. Duong, A. Owusu Obeng, K. J. Cook, N. Seligson, N. Cody, V. F. Funanage, K. V. Blake, S. A. Scott
A26 Sayak Chakravarti Combining single-cell transcriptomics with a novel microfluidic assay to investigate ethnic differences in tumor heterogeneity and plasticity at the sub-clonal level Sayak Chakravarti*, Suman Mazumder, Taraswi Mitra Ghosh, Farnaz Hemmati, Farshad Amiri3, Timothy Moore, Panagiotis Mistriotis, Amit Kumar Mitra
A34 Meghan Chenoweth Genetically faster CYP2B6 activity is associated with smoking cessation success on bupropion: mediating effects of hydroxybupropion on long-lasting cessation Meghan J. Chenoweth*, Annie R. Peng, Andy Z. X. Zhu, Lisa Sanderson Cox, Nikki L. Nollen, Jasjit S. Ahluwalia, Neal L. Benowitz, Jo Knight, Walter Swardfager, Rachel F. Tyndale
B3 Maximilian Choi ABCB1 gene variants and antidepressant response in patients with depression: A systematic review and meta-analysis Leen Magarbeha, Maximilian Choi*,Claudia Hasself, Clement C. Zaib, Stefan Kloiberb, Chad Bousmang, Daniel J. Müllera
A27 Joe Collins Regulation of the CYP3A genes by a distal enhancer and regulatory variants Joe Collins* and Danxin Wang
A24 Amanda Cristofoli Camargo IDENTIFICATION OF ADVERSE DRUG REACTIONS THAT MAY BE RELATED TO PHARMACOGENOMICS IN A PUBLIC HOSPITAL FROM THE SOUTHERN BRAZIL Amanda Cristofoli Camargo*, Mariana Rodrigues Botton, Ursula da Silveira Matte
B21 Brittney Davis Pharmacogenetic predictors of cannabidiol (CBD) plasma levels in treatment-resistant epilepsy Brittney H. Davis*, Jerzy P. Szaflarski; E. Martina Bebin, Nita A. Limdi
A41 Sergio Del Angel Clinical importance of CYP2D6 duplicated allele testing for accurate phenotype prediction Sergio Del Angel*, Whitney Wooderchak-Donahue, Roberta Melis, Yuan Ji, Gwendolyn A. McMillin
A7 Alex del Cueto A multidisciplinary precision medicine approach for integrating routine germline genetic testing into the care for pancreatic cancer patients. Alex del Cueto*, Darcy K. Berry, Andrea Ballard1, Laura V. Barton, Caroline S. Bertsch, Jennifer Brzosowicz, Sarah Burke, Estrella Carballido, Edward D. Esplin, Jason B. Fleming, Bede Daniel Garcia, Kathleen R. Gewandter, Carolyn G. Haskins, Kathryn E. Hatchell, Pamela Hodul, Dae Won Kim, Mokenge Malafa, Scott Michalski, Sarah M. Nielsen, David P. Ranson, Katelynn Simon, Christine B. Steele, Jennifer B. Permuth, J. Kevin Hicks
B25 Bernard Esquivel Integration of a condition-based clinical decision support system Martin Dawes, Hagit Katzov-Eckert, Marysol Garcia-Patiño, Cristina Verzosa, Bernard Esquivel*
A30 Renee Geck Functional interpretation of human G6PD variants using multiplexed analyses in S. cerevisiae Renee C. Geck*, Maya N. Walker, and Maitreya J. Dunham
A2 Haidy Giratallah Variation in a nicotine and nitrosamine metabolism gene associates with lung diseases: A Phenome- wide Association and Mendelian Randomization study in the UK biobank Haidy K. Giratallah, Meghan J. Chenoweth, Jennie Pouget, Ahmed El-Boraie, Caryn Lerman, Jo Knight, Rachel F. Tyndale
A35 Kristin Grimsrud Pilot Analysis of medication associations with CYP2C9, 2C19 and 2D6 haplotypes in pediatric surgery and burn patients *Kristin N. Grimsrud, Ryan R. Davis, Clifford G. Tepper, Tina L. Palmieri
B7 Naomi Gronich Association between CYP2C19 polymorphism and proton pump inhibitors effectiveness and adverse effects in real-life: retrospective cohort study Naomi Gronich*, Idit lavi, Flavio lejbkowicz, Mila Pinchev, Gad Rennert
B26 Zohara Gruen Pharmacogenomics Implementation in the Arthroplasty Setting Zohara Gruen*, Leanne Dumeny, Connie Mei, and Larisa Cavallari
B14 John Harting Resolving Highly Diverse HLA and CYP2D6 Alleles using HiFi Sequencing for Long-Range Amplicon Data with a New Clustering Algorithm” John Harting*, Lei Zhu, Ian McLaughlin, Zev Kronenberg
B17 Marina Hentschke Lopes Frequency of DPYD gene variants and phenotype inference in a Southern Brazilian population Marina Hentschke Lopes*, Mariana Rodrigues Botton, Ursula Matte
B20 Duncan Honeycutt Pharmacogenetic risk factors for escitalopram-induce hyperarousal in youth at high-risk for developing bipolar disorder Duncan C. Honeycutt*, Laura B. Ramsey, Thomas J. Blom, Kaitlyn M. Bruns, Luis R. Patino, Manpreet Singh Melissa P. DelBello
B16 Yingbo Huang Sex differences in the expression and genetic regulation of drug metabolism and transporter genes in human liver. Yingbo Huang*, Feng Li, Weijie Zhang, Yuting Shan, Lee Cheung, Barbara E. Stranger, R. Stephanie Huang
A21 Chaten Jessel Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada Chaten D. Jessel*, Abdullah Al Maruf, Anita Oomen, Paul D. Arnold, Chad A. Bousman
A29 Megan Koleske High-content imaging of 150 OCTN2 transporter variants reveals subcellular localization to be predictive of function Megan L Koleske*, Kathleen M Giacomini
B43 Kyoin Koo Survey of U.S. Medical Oncologists’ Practices and Beliefs regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy Kyoin Koo*, Amy L Pasternak, Daniel L Hertz
A23 Madeline Kreider Medication prescribing predicts utility of panel pharmacogenomic testing in breast cancer patients. Kreider MS*, Haddad AF, Empey PE
A28 Yu-Lin Kuang Mir-192 is a Novel Regulator of GLP1R and Insulin Secretion and Contributes to Statin-induced Diabetes Yu-Lin Kuang*, Antonio Munoz, Yuanyuan Qin, Andrea Dose, Gilbert Nalula, Elizabeth Theusch, Gabriela Sanchez, Meng Liu, Carlos Iribarren, Ronald M. Krauss, Marisa W. Medina
A31 Rebecca Law Evaluating the role of pharmacogenetics in attention-deficit/hyperactivity disorder using human hepatocytes and enzyme inhibition in human liver microsomes Rebecca Law*
A22 Tianna Leitch Pharmacogenetics in pediatric psychiatry: considerations for implementation in rural communities Tianna M. Leitch*, Shayna Killam, Kirk C. Katseanes, Karen E. Brown, Kathleen M. George, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Susan B. Trinidad, Erica L. Woodahl
A38 Lauren Lemke Medicare coverage of pharmacogenomic testing: An overview of the current landscape. Hana Al Alshaykh,* Lauren K. Lemke,* Benish Alam, Emily J. Cicali, Kevin Hicks, Petr Starostik, Julie A. Johnson, Larisa H. Cavallari, Kristin Wiisanen
A18 Binglan Li An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics Binglan Li*, Michelle Whirl-Carrillo, Matt W. Wright, Larry Babb, Heidi L. Rehm, Teri E. Klein
A4 Michelle Liu Composite CYP3A phenotypes influence tacrolimus dose adjusted concentration in lung transplant recipients Michelle Liu*, Ciara M. Shaver, Kelly A. Birdwell, Stephanie A. Heeney, Christian M Shaffer, Sara VanDriest
A6 Elaine Ah gi Lo Selection and Prioritization of Clinically Actionable Drug-Gene Pairs for a Pre-emptive Pharmacogenomics Service in Hospitals and Primary Care Setting s in Singapore. Elaine Ah gi Lo*, Le Xuan Mun, Hwee Lin Wee3Doreen Tan Su-Yin, Benedict Yan, Karen ML Tan, Folefac Aminkeng, Ngiam Kee Yuan, E Shyong Tai, Boon Cher Goh, Clinical Pharmacogenomics Implementation Work Group (CPIWG)
B31 Sarah Lyle Identification of Gene Expression Patterns and Repurposed Therapeutic Agents Associated with Polycystic Ovary Syndrom Sarah M Lyle*, Britt I Drögemöller
B30 Suman Mazumder Differential gene expression analysis at the single-cell level identifies FK866 as a novel secondary drug against taxane resistance and cancer stemness in aggressive prostate cancers Suman Mazumder*, Taraswi Mitra Ghosh, Ujjal Kumar Mukherjee, Sayak Chakravarti, Robert Arnold, Clayton Yates, Amit Kumar Mitra
A16 Bianza Mbavha Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines. Bianza T. Mbavha*, Comfort R. Kanji, Nadina Stadler, Julia Stingl, William Wekwete, Collen Masimirembwa
B32 Taraswi Mitra Ghosh Identification of distinct mRNA & microRNA expression signatures and mRNA-miRNA pairs associated with ethnic differences in prostate cancer aggressiveness Taraswi Mitra Ghosh*, Jason White, Suman Mazumder, Joshua Davis, Grace Hurley, Brian S. Cummings, Amit K. Mitra, Clayton Yates, Robert D. Arnold
A1 Nur Farhana Mohamed Noor Association of NAT2 Polymorphism with Antituberculosis Induced Hepatotoxicity in a case control study. Nur Farhana Mohamed Noor*, Teh Lay Kek, Mohd Arif Mohd Zim, Zamzurina Abu Bakar, Mohd Nur Fakhruzzaman Noorizhab, Noor Izyani Zakaria, Muhammad Imran Lailanor, Mohd Zaki Salleh
B6 Mariangeli Moneró-Paredes PON1 as a biomarker in Caribbean Hispanics resistant to clopidogrel: A multiomic-based approach. Mariangeli Moneró-Paredes*, Ednalise Santiago, Jessicca Y Renta, and Jorge Duconge
B37 Andrew Monte Genome Wide Analysis of Ondansetron Effectiveness in Patients with Nausea and Vomiting Presenting to the Emergency Department Brandon Sonn, Alexis Vest, Richard Puls, Keegan Hovland, Madison Smith, Nichola Rafaels, Andrew A Monte*
B42 Kheireddin Mufti Toward A Comprehensive Assessment of the Genetic Risk of Vincristine- Induced Peripheral Neuropathy Kheireddin Mufti*, Erika N. Scott, Jessica N. Trueman, Jessica Lovnicki, Catrina M. Loucks, Shahrad R. Rassekh, Colin J.D Ross, Bruce C. Carleton, on behalf of the Canadian Pharmacogenomics Network for Drug Safety Consortium
B24 Ankita Narang Whole-genome sequencing analysis of clozapine-induced myocarditis Ankita Narang*, Paul Lacaze, Kathlyn J Ronaldson, John J McNeil, Mahesh Jayaram, Naveen Thomas, Rory Sellmer, David Crockford, Robert Stowe, Steven C. Greenway, Christos Pantelis, Chad A Bousman
B11 Mei Li Ng Single Nucleotide Polymorphisms In SLCO1B1 And UGT1A1 Are Associated With Plasma Exposure Of Atorvastatin And Its Major Metabolites:A SAPhIRE cohort Study Mei Li Ng*, Folefac Aminkeng, E Shyong Tai, J.W.C Tan, Jian Jun Liu, Pakkiri Leroy Sivappiragasam, Yee Wei Loong, Choi Hyungwon, Chester Lee Drum
A9 Rina Nishii NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir Rina Nishii*, Takanori Mizuno, Daniel Rehling, Colton Smith, Brandi L. Clark, Xujie Zhao, Scott A. Brown, Brandon Smart, Takaya Moriyama, Yuji Yamada, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Lei Yang, Wenjian Yang, Paul G. Thomas, Pål Stenmark, Motohiro Kato, Jun J. Yang
A39 Joseph O'Shea Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review. O’Shea J, Ledwidge M, Gallagher J, Keenan C, Ryan C.
B1 Taichi Ochi Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action *Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Anton J.M. Loonen, German G. Simutkin, Nikolay A. Bokhan, Bob Wilffert, Svetlana A. Ivanova
B27 Amy Pasternak Identifying rates of clinically actionable drug-gene interactions in a health-system biorepository to guide pharmacogenetics implementation services Amy L Pasternak*, Kristen M Ward, Madison Irwin, Carl Okerberg, David Hayes, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
A14 Jennie Pouget Exploring the association of CYP2A6 with the nicotine metabolite ratio among African Americans to identify putative causal variants Jennie G. Pouget*, Ahmed El-Boraie, Caryn Lerman, Jo Knight, Lisa Sanderson Cox, Nikki L. Nollen, Jasjit S. Ahluwalia, Meghan J. Chenoweth, Rachel F. Tyndale on behalf of the PNAT team
B4 Ethan Poweleit CYP2C19 Phenotype Influences Escitalopram and Sertraline Pharmacokinetics in Pediatric Patients Ethan A. Poweleit*, Samuel E. Vaughn, Zeruesenay Desta, Jeffrey R. Strawn, Laura B. Ramsey
A10 Nick Powell Life-Threatening Docetaxel-Induced Pneumonitis in a Patient with Loss-of-Function Variants in the Pharmacokinetic Genes CYP3A4 and CYP3A5 Nicholas R. Powell*, Tyler Shugg, Reynold C. Ly, Costantine Albany, Milan Radovich, Bryan P. Schneider, Todd C. Skaar
B19 Ravi Ramalingam Pharmacogenetic evaluations of 6-mercaptopurine mediated toxicity in pediatric acute lymphoblastic leukemia patients from South Indian population Ravi Ramalingam*, Harpreet Kaur, Julius Xavier Scott, Latha, Arathi Srinivasan, Ganesh Prasad ArunKumar, Solomon F. D. Paul
B41 Rizal Husaini Razali Role of MTHFR Polymorphism on Methotrexate Response in Childhood Acute Lymphoblastic Leukemia Rizal Husaini Razali*, Lay Kek Teh, Kok Hoi Teh, Hishamshah Mohd Ibrahim, Mohd Zaki Salleh
A8 Zachary Rivers Metastatic Colorectal Cancer Treatment in the Medicare Population: An analysis to inform preemptive germline pharmacogenomic testing Zachary Rivers*, Helen Parsons, Karen Kuntz, Pamala Jacobson, Joel Farley, David Stenehjem
B28 Zachary Rivers Exposure to Non-Chemotherapy Medications With Pharmacogenomic Risk In Medicare Patients Newly Diagnosed With Metastatic Colorectal Cancer Zachary Rivers*, Helen Parsons, MPH, Karen Kuntz, Pamala Jacobson, Joel Farley, David Stenehjem
A36 Katelyn Rossow Aripiprazole exposure, cytochrome P450 2D6, Autism Spectrum Disorder, and adverse events in children and adolescents Katelyn M. Rossow*, Angela Maxwell-Horn, Andrea Gaedigk, Dan M. Roden, Sara L. Van Driest
B22 Stuart Scott Development and optimization of a 43 gene pharmacogenomic panel using enrichment-based capture and long-read PacBio HiFi sequencing Daniel Portik, Ting Hon, Josiah Wilcox, Yao Yang, Nathan A. Hammond, Zev Kronenberg, Nathaniel Watson, John Harting, Euan Ashley, Janet Ziegle, Stuart A. Scott*, Sarah Kingan
B40 Mohammad Shahbazi Clinical and Genome-Wide Association Analysis of “Speech Recognition Threshold” Following Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer Mohammad Shahbazi*, Xindi Zhang, Paul Dinh, Victoria A. Sanchez, Matthew R. Trendowski, Megan M. Shuey, Regeneron Genetics Center, Nancy Cox, Robert D. Frisina, Lois B. Travis, M. Eileen Dolan  For the Platinum Study Group
B18 Jack Staples Genetic and seasonal determinants of vitamin D status in Confederated Salish and Kootenai Tribes (CSKT) participants Jack W. Staples*, Kathleen M. George, Rachel Dalton, Erin E. Ellerbeck, Genevieve Krause, Tianna Lietch, Theresa Aliwarga, Matthew G. McDonald, Brian R. Phillips, LeeAnna I. Muzquiz, Deborah A. Nickerson, Timothy A. Thornton, Kenneth E. Thummel, Erica L. Woodahl
B2 Kiera Stein SLC6A4 Genetic Variation and Antidepressant Tolerability and Efficacy: A Systematic Review and Meta-Analysis Kiera Stein*, Abdullah Al Maruf, Daniel J. Müller, Jeffry R. Bishop, Chad A. Bousman
A32 Gabriele Stocco Pharmacogenetic analysis, clinical response and adverse effects of thalidomide in pediatric patients with inflammatory bowel disease: a multicenter study Marianna Lucaò, Matteo Bramuzzo, Anna Agrusti, Fabrizio Ecca, Erika Cecchin, Giovanna Zuin, Serena Arrigo, Paolo Lionetti5 Salvatore Pellegrino, Giuseppe Maggior, Giuseppe Toffoli, Gabriele Stocco*, Giuliana Decorti
B33 Gabriele Stocco VARIATION OF MERCAPTOPURINE METABOLITES DURING REMISSION MAINTENANCE THERAPY IN THE AIEOP-BFM 2009 PROTOCOL FOR ACUTE LYMPHOBLASTIC LEUKEMIA: ASSOCIATION WITH DISEASE OUTCOME AND INFLUENCE OF PACSIN2 rs2413739 FRANCA R, GRASSO A, GIURICI N, CURCI D, FAVRETTO D, MICHIELIN F, STOCCO G*, DECORTI G, LOCATELLI F, VINTI L, BIONDI A, COLOMIBINI A, FAGIOLI F, BARISONE E, RABUSIN M
B12 Sudeep Sunthankar Influence of CYP2D6 Genetic Variation on Adverse Events with Propafenone in the Pediatric and Young Adult Population Sudeep Sunthankar*, Andrea Gaedigk, Prince J Kannankeril, Andrew E Radbill, Frank A Fish, Sara L Van Driest
B15 Yi-Ching Tang From cell lines to pharmacogenomics. Transferring deep learning drug response prediction models from cell lines to personalized therapy through molecular pathways Yi-Ching Tang*, Assaf Gottlieb
B34 Elizabeth Theusch ZNF335 is a novel modulator of plasma cholesterol statin response Elizabeth Theusch*, Flora Y. Ting, Ronald M. Krauss, and Marisa W. Medina
B38 Caroline Thom Increasing Complexity in PharmGKB Pharmacogenomic Pathways C.F. Thorn*, L. Gong, R. Huddert, K. Sangkuhl, R. Whaley, M. Woon, M. Whirl-Carrillo and T.E. Klein
B5 Cameron Thomas Examining cardiovascular outcomes with the ABCD-GENE Score among patients receiving CYP2C19-guided antiplatelet therapy after PCI Cameron D. Thomas* Francesco Franchi, Joseph S. Rossi, Amber L. Beitelshees, Ellen C. Keeley, Yan Gong, Julie A. Johnson, R. David Anderson, Richard A Kerensky, Caitrin W. McDonough, George A. Stouffer, Dominick J. Angiolillo, Craig R Lee, Larisa H. Cavallari
B8 Amy Turner CYP2C19 PGx Genotyping Assessment in a Large Multiethnic Population Amy Turner*, Cyrine-Eliana Haidar, Ashley Derezinski, Praful Aggarwal, Gunter Scharer, Ulrich Broeckel
A43 David Twesigomwe Characterisation of CYP2D6 Allelic Variation in African Populations: An Integrative Bioinformatics Approach David Twesigomwe*, Zané Lombard, Scott Hazelhurst on behalf of the Wits-H3A/GSK ADME Collaboration
B29 Jing Wang Mitochondrial DNA copy number was a potential biomarker for treatment choice between metformin and acarbose Wang Jing*, Zhou Kaixin, Wang You, Xu Tao
B23 Michelle Whirl-Carrillo Pharmacogenomics Clinical Annotation Tool (PharmCAT): Current State and Future Directions Michelle Whirl-Carrillo, Katrin Sangkuhl*, Binglan Li, Ryan Whaley, Mark Woon, Karl Keat, Anurag Verma, Shefali Verma, Sony Tuteja, Marylyn D. Ritchie, Teri E. Klein
A17 MacKenzie Wilke A systematic analysis of the use of polygenic risk scores in pharmacogenomics MacKenzie A.P. Wilke*, Sarah M. Lyle*, Danielle Johnson, Kaarina Kowalec, Andrea Jorgensen, Galen E.B. Wright, Britt I. Drögemöller
B39 MacKenzie Wilke Identifying Potential Otoprotectants For the Prevention of Cisplatin-induced Ototoxicity Through Drug Repurposing Analyses MacKenzie A.P. Wilke*, Britt I. Drögemöller
B35 Michael Williams Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population Michael L. Williams*, Prince Kannankeril, Sara L. Van Driest, Leena Choi
A13 Guang Yang Pharmacogenomics of Clopidogrel Response in African Americans: An ACCOuNT Study Guang Yang*, Tanima De, Cristina Alarcon, Juan Avitia, Paula Friedman, Edith Nutescue, Travis O’Brien, Norm Lee, Anelia Horvath, Matthew Tuck, David Meltzer, Minoli A Pere
B9 Neil Yang ZNF335 and CNOT3 affect cellular cholesterol metabolism and statin response in HepG2 cells Neil V Yang*, Sarah King, Antonio Muñoz-Howell, Yuanyuan Qin, Ronald M Krauss, Elizabeth Theusch
A20 Weijie Zhang Computational Drug Discovery in Advanced Prostate Cancer through in vitro Drug Response Modeling Weijie Zhang*, Sampreeti Jena, Adam M. Lee, Josh Mentzer, Alexander Ling, Scott Dehm, R. Stephanie Huang
B36 Xujia Zhou Species Differences in the Function of Three Mammalian Orthologs of Breast Cancer Resistance Protein, BCRP Xujia Zhou*, Sook Wah Yee, Kathleen M Giacomini
A11 Renata Zieger ASSOCIATION BETWEEN VARIANTS IN ABC FAMILY GENES AND ORAL MUCOSITIS SEVERITY IN PEDIATRIC PATIENTS WITH OSTEOSARCOMA Renata de Almeida Zieger, Luísa Comerlato Jardim*, Stéfanie Thieme Perotto, Marina Siebert, Marina Curra, Amanda de Farias Gabriel, Andre Tesainer Brunetto, Lauro José Gregianin, Marco Antonio Trevizani Martins, Ursula da Silveira Matte, Manoela Domingues Martins, Mariana Rodrigues Botton
A19 Rayyan Zuberi The Use and Potential Misuse of Medications with Genotype-Informe Prescribing Guidelines in a Nationally Representative Cohort of US Children Rayyan Zuberi*, Ankita Narang, Chad Bousman

THANK YOU SPONSORS


For information or assistance contact:
Sheilah - info@pgrn.org


Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

Follow us on


Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Founding Members will be listed on the PGRN website. 
Powered by Wild Apricot Membership Software